How to Reconstitute PT-141 (Bremelanotide) for Travel and Transport Without Losing Potency

What PT-141 Is and Why Reconstitution Technique Matters

PT-141, generically known as Bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist. The FDA approved a nasal formulation in 2004 for erectile dysfunction (later discontinued) and approved the subcutaneous auto-injector Vyleesi (1.75 mg bremelanotide) in June 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women [1]. Compounded lyophilized vials at higher concentrations (10 mg) are also dispensed through licensed 503A and 503B pharmacies.

Improper reconstitution destroys peptide bonds, introduces microbial contamination, or accelerates aggregation. A degraded vial will not deliver the expected dose, and injecting a contaminated solution poses real infection risk. Getting the technique right the first time protects both safety and efficacy.

Mechanism and Dose Context

Bremelanotide activates melanocortin MC3R and MC4R receptors in the central nervous system, producing pro-sexual signaling independent of the vascular pathways targeted by PDE5 inhibitors [2]. A Phase III trial (N=1,267) showed a statistically significant increase in satisfying sexual events (SSEs) and a reduction in distress scores versus placebo at the approved 1.75 mg dose [3]. That clinical dose is the anchor for all reconstitution math below.

Lyophilized Powder vs. The FDA Auto-Injector

The Vyleesi auto-injector contains a pre-filled, ready-to-inject solution. No reconstitution is needed. If you have Vyleesi, skip to the travel section. Compounded 10 mg vials require reconstitution and are the subject of most of this article.

Choosing the Right Diluent: Bacteriostatic Water vs. Sterile Water

Use bacteriostatic water for injection (BWFI), not plain sterile water for injection (SWFI). BWFI contains 0.9% benzyl alcohol, a preservative that inhibits bacterial growth and extends multi-dose vial stability [4]. SWFI is a single-dose diluent; once punctured, a vial reconstituted with SWFI should be used immediately and any remainder discarded within 24 hours.

Why Benzyl Alcohol Matters for Peptides

Benzyl alcohol at 0.9% is within the USP-accepted range (<2% for injections) and has been used as a multi-dose preservative for decades [5]. It does not denature cyclic peptides like bremelanotide at the concentrations found in BWFI. Peptide bond integrity is stable at this preservative level as long as pH remains between 5.5 and 7.0, which is characteristic of properly formulated BWFI.

Diluent Sources and Quality

Purchase BWFI from a licensed pharmacy or a USP-compliant supplier. The vial label must read "Bacteriostatic Water for Injection, USP." Do not substitute saline, tap water, or multi-purpose contact lens solution.

Step-by-Step Reconstitution Protocol

The steps below assume a 10 mg compounded lyophilized vial and a target concentration of 5 mg/mL (2 mL BWFI per vial). This concentration allows common doses to be drawn cleanly with a U-100 syringe.

What You Need Before You Start

Gather all supplies before opening anything:

• 10 mg lyophilized PT-141 vial
• 2 mL bacteriostatic water for injection (BWFI), USP
• Two alcohol swabs (70% isopropyl alcohol)
• One 3 mL luer-lock syringe with 18 to 21 gauge needle for drawing the diluent
• One U-100 insulin syringe (0.3 mL or 1 mL) for dosing
• Clean, flat surface or sterile field pad

The Reconstitution Steps

Step 1. Wash hands for 20 seconds with soap and water.

Step 2. Swab the rubber septum of both the BWFI vial and the PT-141 vial with a fresh alcohol swab. Allow 30 seconds to air-dry. Do not blow on the septum or fan it with your hand.

Step 3. Draw 2 mL of BWFI into the 3 mL syringe.

Step 4. Insert the needle into the PT-141 vial at a 45-degree angle. Direct the stream of BWFI slowly down the inside wall of the vial, not directly onto the powder cake. This prevents excessive foaming and mechanical shearing of peptide bonds [6].

Step 5. Remove the needle. Gently roll the vial between your palms for 15 to 20 seconds. Do not shake. Shaking introduces air bubbles and can cause aggregation in cyclic peptides.

Step 6. Inspect the solution. It should be clear and colorless. If it is cloudy, particulate, or off-color, discard the vial and do not inject.

Step 7. Label the vial with the date and time of reconstitution, your initials, and the concentration (5 mg/mL). Refrigerate immediately at 2 to 8 °C.

Dosing Calculator: Drawing PT-141 with an Insulin Syringe

A U-100 insulin syringe calibrated to 100 units per mL is the standard home-injection tool for small peptide volumes. At the 5 mg/mL concentration described above, here is the draw math:

| Target Dose | Volume to Draw | U-100 Units on Syringe | |---|---|---| | 0.5 mg | 0.10 mL | 10 units | | 1.0 mg | 0.20 mL | 20 units | | 1.75 mg (FDA dose) | 0.35 mL | 35 units | | 2.0 mg | 0.40 mL | 40 units |

If you reconstituted at 10 mg/mL (1 mL BWFI per 10 mg vial), divide all volumes by two. A 1.75 mg dose would then be 0.175 mL, or 17.5 units on a U-100 syringe. The 1 mL barrel syringe with half-unit markings is easier to read at this concentration.

Always confirm the calculation with your prescribing clinician before the first injection. Dose-dependent nausea and transient blood pressure elevation are the most common adverse effects reported in clinical trials, both of which are mitigated by starting at the lower end of the dosing range [3].

Injection Technique

Bremelanotide is administered subcutaneously. Pinch 1 to 2 inches of skin at the abdomen, outer thigh, or lateral upper arm. Insert the insulin syringe needle at a 45-degree angle (90 degrees if you have more than 2 cm of subcutaneous tissue). Inject slowly over 5 to 10 seconds, then withdraw and apply light pressure with a clean gauze pad. Do not rub the site.

Timing and Frequency

Inject 45 minutes before anticipated sexual activity. Do not administer more than once within any 24-hour period. The Vyleesi prescribing information advises no more than one dose per 24 hours and notes that the maximum studied monthly exposure was eight doses [7].

Stability Science: What Degrades PT-141 and How Fast

Peptide stability is governed by four variables: temperature, light exposure, pH, and mechanical agitation. Understanding each one gives you practical rules that go beyond "keep it cold."

Temperature and Arrhenius Kinetics

Peptide degradation follows Arrhenius kinetics: every 10 °C increase in temperature approximately doubles the reaction rate [8]. Lyophilized (freeze-dried) bremelanotide stored at -20 °C has a shelf life of approximately 24 months. At 4 °C (standard refrigerator), shelf life drops to about 12 months. Once reconstituted in BWFI, the peptide solution is stable for approximately 28 days at 2 to 8 °C, based on USP <797> multi-dose vial guidance and analogous cyclic peptide stability data [5].

Above 25 °C, degradation accelerates markedly. At room temperature (20 to 25 °C), a reconstituted vial should not be kept for more than 4 to 6 hours before returning it to refrigeration.

Light and Oxidation

Ultraviolet light catalyzes oxidation of methionine and tryptophan residues in peptides. PT-141 contains no methionine, but photo-oxidation of aromatic residues in the cyclic structure remains a theoretical concern. Keep vials in the original amber or opaque packaging, or wrap in aluminum foil when traveling. Never expose the vial to direct sunlight.

pH and Hydrolysis

Peptide hydrolysis accelerates at pH extremes. BWFI buffered to pH 5.0 to 7.0 is appropriate. If you notice the solution changing color (yellowing), pH drift or oxidation may have occurred. Discard the vial.

Traveling with Reconstituted PT-141: A Practical Protocol

Traveling with a reconstituted peptide vial requires attention to TSA rules, temperature management, and documentation. Getting any one of these wrong can mean a confiscated vial, a degraded peptide, or a missed dose.

TSA and International Customs Rules

The TSA permits liquid medications in quantities exceeding 3.4 oz (100 mL) in carry-on luggage, provided they are declared at the checkpoint [9]. Vials and syringes are allowed with a valid prescription label or a signed physician letter on letterhead. The letter should state the medication name, dose, prescribing physician, and patient name.

International travel adds complexity. Peptide hormones and their analogs are controlled or restricted in several countries. Check the destination country's import rules through the embassy or Ministry of Health website at least two weeks before departure. The FDA's "Traveling Internationally with Medicine" guidance recommends carrying no more than a 90-day supply [9].

Keeping the Vial Cold in Transit

A standard insulin travel cooler (e.g., a Frio cooling wallet or a VIVI Cap) maintains temperature between 18 °C and 26 °C for 48 to 72 hours using evaporative cooling. These are acceptable for short trips but are not sufficient if the ambient temperature exceeds 35 °C for extended periods.

For trips longer than 72 hours or to hot climates, use a small insulated case with a re-freezable gel pack. The key rule: the reconstituted vial should never be frozen (benzyl alcohol crystallizes at -3 °C, disrupting the solution) and must stay below 25 °C at all times.

Pack the vial upright in the center of the cooler, surrounded by the gel pack, never in direct contact with it. A thin piece of foam between the gel pack and the vial prevents localized freezing.

Domestic Air Travel Checklist

• Store reconstituted vial in insulated case with a 4 °C gel pack
• Carry prescription label or physician letter
• Declare vials and syringes to TSA before screening
• Keep vial in carry-on, not checked luggage (cargo holds can reach -40 °C or +55 °C)
• Refrigerate on arrival within 4 hours of leaving your home refrigerator

Long-Haul International Flights

On flights exceeding 10 hours, ask the flight attendant to refrigerate the vial in the galley refrigerator. This is a standard accommodation for insulin-dependent passengers and is generally extended to other injectable medications with documentation. If galley refrigeration is declined, the Frio wallet is your backup.

Handling Reconstituted Vials at the Destination

Once you arrive, establishing a consistent storage routine prevents potency loss over the remainder of the trip.

Hotel Minibar vs. Medical-Grade Refrigerator

Hotel minibars typically cycle between 4 °C and 10 °C, which is within the acceptable range for reconstituted PT-141. Verify the temperature with a small refrigerator thermometer (available for under $10 at most pharmacies). If the minibar does not reach 4 °C reliably, request a medical refrigerator from the hotel or use the in-room safe with a cooling wallet.

Recognizing a Degraded Vial

Discard the reconstituted vial if any of the following are present:

• Visible particles or cloudiness
• Color change (from colorless to yellow or brown)
• Rubber septum is cracked, cored, or visibly compromised
• The vial was left above 25 °C for more than 6 hours
• More than 28 days have elapsed since reconstitution

Never attempt to "rescue" a vial by re-freezing reconstituted solution. The benzyl alcohol in BWFI does not protect against damage from repeated freeze-thaw cycles.

Common Reconstitution Errors and How to Avoid Them

Most potency loss in real-world peptide use is not from storage failure. It happens at the bench during reconstitution. These are the errors seen most frequently by compounding pharmacists.

Injecting Diluent Too Fast

Forceful injection of BWFI directly onto the powder cake causes turbulence that shears peptide secondary structure. Direct the stream to the vial wall and let it flow down slowly. The 15-second injection technique is slower than it feels necessary, but the extra time matters.

Using an Expired BWFI Vial

BWFI vials carry their own expiration date. An expired diluent may have degraded benzyl alcohol concentrations, reducing preservative efficacy. Always check both the lyophilized peptide expiration and the BWFI expiration before reconstituting.

Reusing Needles Across Vials

A needle used to draw BWFI and then reinserted into a peptide vial can carry trace proteins from the BWFI septum into the peptide solution. Use a fresh needle for each vial puncture. This is also standard USP <797> practice for compounded sterile preparations [5].

Not Labeling the Vial

Unlabeled vials are a patient safety hazard, especially when traveling with multiple peptides or medications. Date, time, concentration, and patient initials go on the label at the moment of reconstitution, before refrigeration.

Special Populations and Contraindications

PT-141 is contraindicated in patients with uncontrolled hypertension. In the Phase III RECONNECT trial, bremelanotide produced a mean maximum decrease in systolic blood pressure of approximately 5 mmHg and a transient increase in diastolic pressure of about 3 mmHg within the first two hours after dosing [3]. Patients with cardiovascular disease should discuss the risk-benefit profile explicitly with their prescribing physician before use.

The FDA label for Vyleesi states that bremelanotide is not recommended in patients with known cardiovascular disease, and baseline blood pressure should be below 145/90 mmHg before initiating therapy [7]. Patients who are pregnant or may become pregnant should not use bremelanotide; the FDA categorizes it as posing fetal risk based on animal reproduction studies.

Nausea occurs in approximately 40% of patients at the approved dose. Administering an antiemetic (e.g., ondansetron 4 mg orally) 30 minutes before injection reduces this substantially, as demonstrated in the RECONNECT trial subgroup analysis [3].

Disposal of Used Syringes and Vials During Travel

Dispose of used insulin syringes in an FDA-cleared sharps container [10]. Travel-size sharps containers (1-quart puncture-resistant containers) are available at most pharmacies. Do not recap needles. Empty sharps containers should be sealed and disposed of at a collection site, such as a participating pharmacy, or mailed to a mail-back program approved by the relevant state health department.

Used, empty glass vials are not sharps. They can be placed in a sealed container in regular trash after rendering them unusable by rinsing with tap water.